Products

EGFR 18-21 MASTR - Multiplicom

Mutations in the exons 18 to 21 of the EGFR gene

The EGFR MASTR assay amplifies exons 18 to 21 of the EGFR gene and consists of 4 amplicons in a single multiplex PCR reaction. Amplicon sizes range from 100 bp to 180 bp enabling mutation detection in FFPE derived DNA.

The Epidermal Growth Factor Receptor (EGFR) is a cellular transmembrane receptor found on the cell surface of tumour cells. It is activated by the binding of the EGF or other growth factors which finally stimulates cell proliferation. Mutations in the tyrosine kinase domain, comprised by exons 18-21, of the EGFR gene increase the activity of the intracellular signaling cascade resulting in uncontrolled proliferation of the tumor cells, such as non-small cell lung cancer (NSCLC). Identifying the TK domain mutations is applied in guiding targetted therapy strategies with tyrosine kinase inhibitors.

Note: This assay is to be used for research use only.

Show more

http://www.multiplicom.com/product/egfr-18-21-mastr-0
Petra Kupková

Sales Manager

Petra

Kupková

+420 731 426 051

Send Message

Related products

These kits are to be used for the second PCR step to incorporate barcoding and adaptors required for 454 GS Junior or 454 GS FLX instruments (Roche).

show detail

These kits are to be used in combination with the MASTR™ assays.

show detail

The kits are to be used in combination with the MASTR™ assays for the second PCR to incorporate barcoding and adaptors required for the Ion PGM™ System.

show detail

The QC plex assay enables the qualitative and quantitative assessment of human DNA.

show detail

This assay is to be used in combination with the MASTR assays, for applications on

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey